Amgen, Regeneron, Sanofi, Cigna Corp. sales and marketing update

Cigna signed outcomes-based pricing contracts covering marketed, cholesterol-lowering, anti- PCSK9 mAbs Praluent alirocumab from Regeneron and Sanofi and Repatha evolocumab from Amgen. Cigna said th...